SCHEMBL21189185

SCHEMBL21189185

COC(=O)N[C@H]1CCOc2c(C(=O)Nc3cccc(Cl)c3)cccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 3/20 0.45
HPGD P15428 2/20 0.45
ALOX15 P16050 1/20 0.45
KMT2A Q03164 3/20 0.44
EGFR P00533 1/20 0.43
GRM5 P41594 4/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
MAOB P27338 2/20 0.43
HDAC8 Q9BY41 1/20 0.42
P2RX1 P51575 1/20 0.42
P2RX4 Q99571 1/20 0.42
P2RX7 Q99572 1/20 0.42
APOB P04114 1/20 0.42
MTTP P55157 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973497 0.89 KMT2A (0.48) FADS1HPGDKMT2AEGFRGRM5
SCHEMBL19973498 0.89 KMT2A (0.48) FADS1HPGDKMT2AEGFRGRM5
SCHEMBL21189407 0.89 CREBBP (0.42) HPGDKMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL21189278 0.89 FADS1 (0.46) FADS1HPGDKMT2ARAB9ANPC1
SCHEMBL21189206 0.87 TP53 (0.42) HPGDRAB9ANPC1MAOBAPOB
SCHEMBL21189262 0.87 TP53 (0.42) HPGDRAB9ANPC1MAOBAPOB
SCHEMBL21189485 0.87 TP53 (0.42) HPGDRAB9ANPC1MAOBAPOB
SCHEMBL21189284 0.85 APOB (0.42) HPGDRAB9ANPC1APOBMTTP
SCHEMBL21189489 0.85 HTT (0.47) KMT2AGRM5P2RX1HTT
SCHEMBL19973620 0.85 RXFP1 (0.51) P2RX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS FADS1 2483/4885HPGD 3135/4885ALOX15 4718/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS FADS1 2483/4885HPGD 3135/4885ALOX15 4718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.